Why is Vaishali Pharma falling/rising?

As of 30-Jun, Vaishali Pharma Ltd's stock price is currently at 11.60, reflecting an increase of 0.06 or 0.52%. The stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a downward trend in its price performance. Over the past week, the stock has decreased by 4.76%, and it has also shown significant declines over the past month and year, with returns of -8.59% and -26.01%, respectively. Despite these negative trends, there has been a rise in investor participation, with delivery volume increasing by 29.55% compared to the 5-day average. However, the company faces challenges, including operating losses and a weak ability to service its debt, which contribute to its classification as a strong sell.
In the broader market context, Vaishali Pharma's recent performance contrasts sharply with the Sensex, which has gained 2.18% over the past week. The stock's long-term performance is also concerning, as it has underperformed the BSE 500 over the last three years, one year, and three months. The company has generated a return of -33.68% year-to-date, while the benchmark has increased by 7.92%. This underperformance, coupled with a poor EBIT to interest ratio and low profitability per unit of shareholders' funds, suggests that the stock is struggling to attract investor confidence in a market that is otherwise showing positive trends.